NCT06050811View on ClinicalTrials.gov

Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC)

NARecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 3, 2024

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Ulcerative Colitis
Interventions
DIETARY_SUPPLEMENT

2'-Fucosyllactose

2'-Fucosyllactose given orally with water or food for four weeks, followed by a three week washout period.

DIETARY_SUPPLEMENT

Placebo

Maltodextrin given orally with water or food for four weeks, followed by a three week washout period.

Trial Locations (1)

RG1 5AN

RECRUITING

Royal Berkshire NHS Foundation Trust, Reading

All Listed Sponsors
collaborator

University of Reading

OTHER

lead

Royal Berkshire NHS Foundation Trust

OTHER_GOV